- Coordinator
- Institut National De La Sante Et De La Recherche Medicale, France
- Runs
- 1 January 2027 to 31 December 2030
- Status
- Running
- EU funding
- €4.6m
- Total cost
- —
- Partners
- 27 organisations in 12 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101312602
What the project is doing
In the project's own words, from its summary on CORDIS.
Decoding how the “non-coding” genome controls gene expression is one of the grand challenges of modern biomedicine. Most disease-associated variants fall in regulatory DNA, yet their effects on gene regulation remain largely unpredictable, limiting diagnosis, risk stratification and the design of safe gene and cell therapies. cisCODE is an MSCA Doctoral Network that will train 15 Doctoral Candidates to crack the cis-regulatory code by combining cutting-edge genomics with artificial intelligence and synthetic biology.
The network gathers 13 academic partners, completed with 9 non-academic partners across experimental and computational disciplines. Together, they will (i) decode the sequence “grammar” and modular function of cis-regulatory elements, (ii) map the rules of communication and compatibility between distal enhancers and promoters in three-dimensional chromatin, and (iii) build causal, predictive enhancer-based gene regulatory networks in health, stress, inflammation and cancer.
Doctoral projects will leverage single-cell multi-omics, high-throughput functional assays, advanced 3D genome profiling and next-generation AI models to move from descriptive catalogues to mechanistic and predictive understanding.cisCODE is also a training engine for Europe. A structured, international and intersectoral programme will provide Doctoral Candidates with personalised research and career development plans, network-wide schools, secondments in industry and clinics, and dedicated training in open science, data stewardship, ethics and innovation.
By delivering new models, datasets and synthetic regulatory tools openly to the community, cisCODE will accelerate interpretation of regulatory variants, support the rational design of precision therapies, and consolidate Europe’s leadership at the interface of regulatory genomics, artificial intelligence and personalised medicine.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Coordinator |
| Universitat Wien | Wien | Austria | Participant |
| Katholieke Universiteit Leuven | Leuven | Belgium | Associatedpartner |
| Vib Vzw | Zwijnaarde - Gent | Belgium | Participant |
| Alithea Genomics SA | Cossonay | Switzerland | Associatedpartner |
| Ecole Polytechnique Federale De Lausanne | Lausanne | Switzerland | Participant |
| Universitat Basel | Basel | Switzerland | Participant |
| Univerzita Karlova | Praha 1 | Czechia | Associatedpartner |
| Ustav Molekularni Genetiky Av Cr V.v.i. | Praha 4 | Czechia | Participant |
| Lucid Genomics GbmH | Berlin | Germany | Associatedpartner |
| Kobenhavns Universitet | Kobenhavn | Denmark | Participant |
| Syddansk Universitet | Odense M | Denmark | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Fundacio Centre De Regulacio Genomica | Barcelona | Spain | Participant |
| Universidad De Cantabria | Santander | Spain | Associatedpartner |
| Universidad Pompeu Fabra | Barcelona | Spain | Associatedpartner |
| Kom | Nimes | France | Associatedpartner |
| Sadouni | Marseille | France | Associatedpartner |
| Universite D'aix Marseille | Marseille | France | Associatedpartner |
| Istituto Europeo Di Oncologia SRL | Milano | Italy | Participant |
| Universita Degli Studi Di Milano | Milano | Italy | Associatedpartner |
| Annogen B.V. | Amsterdam | Netherlands | Associatedpartner |
| Vassilios Triantis | Amsterdam | Netherlands | Associatedpartner |
| Instytut Biologii Doswiadczalnej Im. M. Nenckiego Polskiej Akademii Nauk | Warszawa | Poland | Participant |
| Politechnika Warszawska | Warszawa | Poland | Participant |
| Enhanc3D Genomics | Cambridge | United Kingdom | Associatedpartner |
| Imperial College of Science Technology and Medicine | London | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI